United Therapeutics reports ‘best quarter’ to date. Here’s what comes next.

United Therapeutics Inc. opened 2022 with a big splash in the organ transplantation arena, but it’s not the only reason Chairperson and CEO Martine Rothblatt called the first few months “the best quarter we have ever reported” for the business. That conclusion considers “not only profits,” but also “patients and our contributions to our planetary community,” Rothblatt said on a first-quarter company earnings call Wednesday. The Silver Spring drugmaker reported $461.9 million in revenue for the first quarter, up 22% from $379.1 million in the first quarter of 2021, with nearly a quarter-billion dollars in quarterly profits, Rothblatt, also UT’s founder, said on the call.